Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15751 - 15775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Camptothecin	Investigational	BIRC5	332	upregulated	Camptothecin results in increased expression of BIRC5 mRNA	17q25.3	A21497
Camptothecin	Investigational	BRCA1	672	downregulated	Camptothecin results in decreased expression of BRCA1 mRNA	17q21.31	A21498
Camptothecin	Investigational	BRCA2	675	downregulated	Camptothecin results in decreased expression of BRCA2 mRNA	13q13.1	A21498
Camptothecin	Investigational	CAB39	51719	downregulated	Camptothecin results in decreased expression of CAB39 mRNA	2q37.1	A20666
Camptothecin	Investigational	CASP2	835	upregulated	Camptothecin results in increased expression of CASP2 mRNA alternative form	7q34	A20664
Camptothecin	Investigational	CDKN1A	1026	upregulated	Camptothecin results in increased expression of CDKN1A mRNA	6p21.2	A21499
Camptothecin	Investigational	CEACAM1	634	upregulated	Camptothecin results in increased expression of CEACAM1 mRNA	19q13.2	A20666
Camptothecin	Investigational	CEBPZ	10153	downregulated	Camptothecin results in decreased expression of CEBPZ mRNA	2p22.2	A20666
Camptothecin	Investigational	DPYD	1806	downregulated	Camptothecin results in decreased expression of DPYD mRNA	1p21.3	A21500
Camptothecin	Investigational	EI24	9538	upregulated	Camptothecin results in increased expression of EI24 mRNA	11q24.2	A20666
Camptothecin	Investigational	EP300	2033	downregulated	Camptothecin results in decreased expression of EP300 mRNA	22q13.2	A21498
Camptothecin	Investigational	EPM2AIP1	9852	upregulated	Camptothecin results in increased expression of EPM2AIP1 mRNA	3p22.2	A20666
Camptothecin	Investigational	ERCC1	2067	downregulated	Camptothecin results in decreased expression of ERCC1 mRNA	19q13.32	A21496
Camptothecin	Investigational	FDXR	2232	upregulated	Camptothecin results in increased expression of FDXR mRNA	17q25.1	A20666
Camptothecin	Investigational	GADD45A	1647	downregulated	Camptothecin results in decreased expression of GADD45A mRNA	1p31.3	A21496
Camptothecin	Investigational	GADD45G	10912	upregulated	Camptothecin results in increased expression of GADD45G mRNA	9q22.2	A21496
Camptothecin	Investigational	HAMP	57817	downregulated	Camptothecin results in decreased expression of HAMP mRNA	19q13.12	A20683
Camptothecin	Investigational	LGALS1	3956	downregulated	Camptothecin results in decreased expression of LGALS1 mRNA	22q13.1	A21501
Camptothecin	Investigational	MAP2K3	5606	upregulated	Camptothecin results in increased expression of MAP2K3 mRNA	17p11.2	A20666
Camptothecin	Investigational	MAP3K5	4217	downregulated	Camptothecin results in decreased expression of MAP3K5 mRNA	6q23.3	A20666
Camptothecin	Investigational	MAPT	4137	downregulated	Camptothecin results in decreased expression of MAPT mRNA	17q21.31	A20499
Camptothecin	Investigational	MGMT	4255	downregulated	Camptothecin results in decreased expression of MGMT mRNA	10q26.3	A21502
Camptothecin	Investigational	MIR145	406937	downregulated	Camptothecin results in decreased expression of MIR145 mRNA	5q32	A21497
Camptothecin	Investigational	MIR145	406937	upregulated	Camptothecin results in increased expression of MIR145 mRNA	5q32	A21497
Camptothecin	Investigational	MIR15A	406948	downregulated	Camptothecin results in decreased expression of MIR15A mRNA	13q14.2	A21497

Displaying entries 15751 - 15775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability